Ignite Creation Date:
2025-12-25 @ 1:45 AM
Ignite Modification Date:
2026-02-22 @ 9:35 PM
Study NCT ID:
NCT03786094
Status:
TERMINATED
Last Update Posted:
2023-11-01
First Post:
2018-12-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer
Sponsor:
Spexis AG
Organization: